Search Results - Sandoz,

Novartis' Sandoz: Between Generics and Pharma

Authors: Carin-Isabel Knoop Krishna G. Palepu

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

Willa Cather and Mari Sandoz: The Muse and the Story Catcher in the Capital City.

Authors: KETCHAM, SALLIE

Source: Cather Studies. 2025, Vol. 14, p203-233. 31p.

MarketLine Company Profile: Sandoz International GmbH.

Source: Sandoz International GmbH MarketLine Company Profile. 11/26/2024, p1-29. 29p.

Sandoz Studies, Volume 1 : Women in the Writings of Mari Sandoz

Authors: Renée M. Laegreid Shannon D. Smith

Resource Type: eBook.

Subjects: Women in literature

Categories: LITERARY CRITICISM / American / General, HISTORY / United States / State & Local / Midwest (IA, IL, IN, KS, MI, MN, MO, ND, NE, OH, SD, WI), LITERARY CRITICISM / Women Authors

Le fantastique de Maurice Sandoz : Le cas du Labyrinthe. (French)

Authors: Van Cutsem, Pierre¹, pierre.van_cutsem@us.edu.pl

Source: Acta Universitatis Lodziensis: Folia Litteraria Romanica; 2023, Vol. 18, p199-211, 13p

Sandoz International GmbH. SWOT Analysis.

Source: Sandoz International GmbH SWOT Analysis. 11/26/2024, p1-7. 7p.

Letters of Mari Sandoz

Authors: Mari Sandoz Helen Winter Stauffer

Resource Type: eBook.

Subjects: Western stories--Authorship, Authors, American--20th century--Correspondence

Categories: LITERARY COLLECTIONS / Letters, LITERARY CRITICISM / General

Sandoz Targets $650 Billion Opportunity With Biosimilars Unit.

Authors: Demetz, Isabel Doenecke, Paula

Source: Bloomberg.com. 3/10/2026, pN.PAG-N.PAG. 1p.

MarketLine Company Profile: Sandoz International GmbH.

Source: Sandoz International GmbH MarketLine Company Profile. 9/4/2023, p1-29. 29p.

In-Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions: Stability of Sandoz Rituximab Biosimilar at Prolonged Room Temperature Conditions: R. Borišek et al

Authors: Borišek, Roman Mischo, André Foierl, Tobias

Source: Drugs in R&D. Dec2024, Vol. 24 Issue 4, p553-561. 9p.

Sandoz International GmbH SWOT Analysis.

Source: Sandoz International GmbH SWOT Analysis. 9/4/2023, p1-7. 7p.

Antibiotics Must Cost More Than M&Ms, Sandoz Tells Governments.

Authors: Doenecke, Paula (AUTHOR)

Source: Bloomberg.com. 10/30/2025, pN.PAG-N.PAG. 1p.

Duke Univ. v. Sandoz Inc.: United States Court of Appeals of the Federal Circuit, 2025 160 F.4th 1305.

Authors: HOLMAN, CHRISTOPHER M.¹ (AUTHOR) holmancm@umkc.edu

Source: Biotechnology Law Report. Apr2026, Vol. 45 Issue 2, p148-154. 7p.

MarketLine Company Profile: Sandoz International GmbH.

Source: Sandoz International GmbH MarketLine Company Profile. 9/14/2022, p1-28. 28p.

Sandoz riposte contre les antibiotiques chinois.

Source: Challenges. 6/11/2026, pN.PAG-N.PAG. 1p.

MarketLine Company Profile: Sandoz International GmbH.

Source: Sandoz International GmbH MarketLine Company Profile. 9/3/2021, p1-28. 28p.

Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP.

Authors: Kubuschok B Otremba B Welslau M et al.

Source: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 3165-3178. Date of Electronic Publication: 2024 Jun 20.

Publication Type: Journal Article; Multicenter Study; Clinical Trial

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

MarketLine Company Profile: Sandoz International GmbH.

Source: Sandoz International GmbH MarketLine Company Profile. 11/20/2020, p1-27. 27p.

Sandoz International GmbH SWOT Analysis.

Source: Sandoz International GmbH SWOT Analysis. 9/14/2022, p1-7. 7p.

SANDOZ INC. V. AMGEN INC.: REMOVING BARRIERS TO MARKET ACCESS FOR BIOSIMILAR MANUFACTURERS.

Authors: KOYA, MOYOSORE O.¹

Source: Journal of Health Care Law & Policy. 2019, Vol. 22 Issue 2, p75-98. 24p.